XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.2
Stock-based Compensation (Tables)
6 Months Ended
Jun. 30, 2019
Summary of stock-based compensation

Three months ended June 30, 

Six months ended June 30, 

2019

2018

2019

2018

Research and development expenses

$

514

    

$

380

$

1,081

    

$

703

Selling, general and administrative expenses

 

3,648

 

3,146

 

7,344

 

5,551

Total stock-based compensation expense

$

4,162

$

3,526

$

8,425

$

6,254

Summary of restricted stock units activity

Weighted-Average

Shares

Grant Date Fair Value

Outstanding at December 31, 2018

514,603

$

20.67

Granted

590,205

15.78

Vested

(127,787)

21.54

Forfeited

(84,784)

18.26

Outstanding at June 30, 2019

892,237

$

17.54

Summary of stock option activity

 

 

 

Weighted-

 

 

Weighted-

 

Average

 

Average

 

Remaining

Aggregate

Exercise Price

 

Contractual

Intrinsic

    

Shares

    

per Share

    

Term (in years)

    

Value

Outstanding at December 31, 2018

 

3,585,856

$

16.20

 

8.0

$

11,170

Granted

 

897,312

 

15.67

Exercised

 

(26,911)

11.30

Cancelled

 

(266,141)

 

17.61

Outstanding at June 30, 2019

 

4,190,116

$

16.03

 

7.7

$

5,248

Exercisable at June 30, 2019

 

2,113,346

$

14.45

 

6.6

$

4,285

Schedule of fair value assumption using Black-Scholes option-pricing model

Six months ended June 30, 

2019

2018

Risk-free interest rate

2.6

%  

2.6

%  

Volatility

63.3

%  

65.0

%  

Expected term (years)

6.06

6.11

Expected dividend yield

%  

%  

Performance share units  
Summary of stock option activity

Weighted-Average

Shares

Grant Date Fair Value

Outstanding at December 31, 2018

$

Granted

99,400

15.90

Outstanding at June 30, 2019

99,400

$

15.90